Analgesia Comparison of Nalbuphine and Morphine for Laparoscopic Myomectomy

Peking University First Hospital80 enrolled

Overview

to compare the analgesia and side effect of nalbuphine and morphine for elective Laparoscopic myomectomy.

To compare the analgesia and side effect of nalbuphine and morphine for elective Laparoscopic myomectomy, by using patient controlled analgesia postoperatively, a randomized, double blind clinical trial. Patients undergoing elective Laparoscopic myomectomy are randomly divided into two groups: nalbuphine and morphine groups. All patients are under general anesthesia with routine methods. The nalbuphine group receive postoperative patient controlled analgesia using nalbuphine 30mg/120ml, while the morphine group receive postoperative patient controlled analgesia using morphine 60mg/120ml. Perioperative parameters are to be collected to compare the two groups.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

Conditions

Postoperative Pain

Interventions

NalbuphineDRUG

patient controlled analgesia with Nalbuphine

MorphineDRUG

patient controlled analgesia with Morphine

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * elective Laparoscopic myomectomy patients 24hr post-operative patient controlled analgesia analgesia no mild or severe liver or renal disfunction Exclusion Criteria: * can't understand patient controlled analgesia device refuse trial

Locations (1)

First hospital Peking University

Beijing, Beijing Municipality, China

Outcomes

Primary Outcomes

numerical rating scale

1-10

Time frame: 24 hr post-operatively

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.